gemini-2.5-flash-lite-preview-09-2025| input-price: 0.1 output-price: 0.4 max-context-length: 128_000 (cost: $0.002) Β· Anfrage: 2025-10-20T07:14:00.545166

Generated by rs-summarizer Version unbekannt

Abstract:

This presentation appears to be a review or teaching session focused on the histopathological diagnosis and differential diagnosis of a specific type of cutaneous spindle cell neoplasm, identified microscopically as an ulcerated, pleomorphic lesion slamming against the epidermis with high mitotic activity. The primary focus is on distinguishing between Atypical Fibroxanthoma (AFX) and other high-grade spindle cell tumors like Spindle Cell Squamous Cell Carcinoma (SCC) and various sarcomas (e.g., Leiomyosarcoma, Rhabdomyosarcoma, Angiosarcoma). The presenter outlines a systematic immunohistochemical approach, emphasizing markers like S100/SOX10 (to rule out melanoma), P40/CK5 (for SCC), and ERG/CD31 (for Angiosarcoma). While AFX and Pleomorphic Dermal Sarcoma (PDS) are considered the same entity at different stages, AFX is reserved for smaller, dermally confined lesions with a good prognosis, whereas PDS applies when the tumor invades the subcutis or shows aggressive features. A specific question regarding the occurrence of Rhabdomyosarcoma in the skin is addressed, explaining its presumed origin from a primitive precursor stem cell, despite the lack of obvious normal skeletal muscle counterpart in that location.

Pathology Case Review: Differential Diagnosis of Pleomorphic Spindle Cell Lesions in the Skin

Summary Rating: No ratings yet
Article Rating: No ratings yet

Source